Analysis of clinical efficacy of spinal cord stimulation therapy in clinical application of neuropathic pain

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038211

Enrollment

Unknown

Registered

2020-09-13

Start date

2020-09-20

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain

Interventions

SCS Group:spinal cord stimulation therapy

Control Group:medical treatement

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients older than 18 years old; 2. Patients with duration of disease >= 3 months (persistent or recurrent) and vas >= 4 points; 3. For patients who meet the diagnostic criteria of neuropathic pain, the diagnosis was made by two attending physicians who have been engaged in pain specialty for three years or more; 4. Patients whose mother tongue is Chinese, with high school education or above, can understand Putonghua and have the ability of autonomous behavior.

Exclusion criteria

Exclusion criteria: 1. Patients with mixed pain; 2. Patients without autonomous behavior ability and unable to read and write Chinese; 3. Patients with puncture site infection, severe cardiopulmonary dysfunction, coagulation dysfunction, etc.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;	—

Secondary

Measure	Time frame
leeds assessment of neuropathic symptoms and sign;Short-form McGill Pain Questionnaire-2;Hospital Anxiety and Depression Scale;Pittsburgh sleep quality index;	—

Countries

China

Contacts

Public ContactXiaochong Fan

The First Affiliated Hospital of Zhengzhou University

fccfxc@zzu.edu.cn+86 13513807717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026